ArticleHaematologica2022

Risk factors for endocrine complications in transfusion-dependent thalassemia patients on chelation therapy with deferasirox: a risk assessment study from a multi-center nation-wide cohort.

Maddalena Casale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.